Clinical trial

Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods

Aliases
2022003195, NCT05389930
Name
2022003195
Description
This study employs a repeated measures experimental design to examine the effect of THC-dominant dose of cannabis and CBD-dominant dose of cannabis, relative to placebo, on subsequent drinking in an alcohol choice task in which participants choose either to drink or receive monetary reinforcement for drinks not consumed. Cannabis will be administered simultaneously with an alcohol-priming dose or alcohol placebo. The study will enroll up to 350 nontreatment-seeking heavy episodic alcohol drinkers who use cannabis weekly.
Trial arms
Trial start
2023-03-16
Estimated PCD
2027-03-31
Trial end
2027-03-31
Status
Recruiting
Phase
Early phase I
Treatment
THC-dominant cannabis
Smoked cannabis with 9.53% THC and 0.09% CBD
Arms:
Alcohol placebo dose, Alcohol priming dose
CBD-dominant cannabis
Smoked cannabis with 0.35% THC and 11.27% CBD
Arms:
Alcohol placebo dose, Alcohol priming dose
Cannabis placebo
Smoked placebo cannabis plant material
Arms:
Alcohol placebo dose, Alcohol priming dose
Alcohol
Drink containing 0.3 g/kg of alcohol
Arms:
CBD-dominant cannabis dose, Placebo, THC-dominant cannabis dose
Alcohol placebo
Placebo beverage contains only juice and a negligible trace of alcohol for masking
Arms:
CBD-dominant cannabis dose, Placebo, THC-dominant cannabis dose
Size
350
Primary endpoint
ml of alcohol consumed
post-smoking during two-hours of the alcohol choice task
Eligibility criteria
Inclusion Criteria: * Age 21 to 50 * English-speaking * cannabis smoking in past two months * heavy drinking in past two months * in good physical health and weighing \< 250 lbs * zero breath alcohol at each visit Exclusion Criteria: * positive pregnancy test * nursing * positive urine toxicology screen for drugs other than cannabis * interest to quit or receive treatment for cannabis or alcohol use
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['PHASE2'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'FACTORIAL', 'interventionModelDescription': 'Mixed factorial design will use a 3 (within-subjects; cannabinoid dose: 9.53% THC/0.06% CBD, 11.27% CBD/0.35% THC, placebo) X 2 (between-subjects; cannabis + an alcohol-priming dose (0.3 g/kg) versus cannabis + alcohol placebo)', 'primaryPurpose': 'BASIC_SCIENCE', 'maskingInfo': {'masking': 'DOUBLE', 'maskingDescription': 'Participants are masked. Outcome assessors who have contact with participants are masked.', 'whoMasked': ['PARTICIPANT', 'OUTCOMES_ASSESSOR']}}, 'enrollmentInfo': {'count': 350, 'type': 'ESTIMATED'}}
Updated at
2024-08-06

1 organization

3 products

4 indications

Organization
Brown University
Indication
Cannabis Use
Indication
Marijuana
Product
Cannabis